DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
POLAPREZINC
2
Small molecule
Investigational
Unknown
Unknown
Peripheral Arterial Disease; Persian Gulf Syndrome; Schizophrenia
Unknown
POLAPREZINC
×
Maximum Phase:
2
First Approval:
None
UNII:
8HO6PVN24W
Molecule Type:
Small molecule
Molecular Formula:
C9H14N4O3
Molecular Weight:
226.24
AlogP:
-1.13
PSA:
121.1
HBD:
4.0
HBA:
#RotB:
6.0
Source:
JNJ-40411813
2
Small molecule
Investigational
Unknown
Unknown
Perceptual Disorders; Depressive Disorder, Major; Schizophrenia; Seizures
Metabotropic glutamate receptor 2 positive allosteric modulator
JNJ-40411813
×
Maximum Phase:
2
First Approval:
None
UNII:
612BYT76F3
Molecule Type:
Small molecule
Molecular Formula:
C20H25ClN2O
Molecular Weight:
344.89
AlogP:
4.69
PSA:
25.24
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PRITELIVIR
2
Small molecule
Investigational
Unknown
Unknown
Herpes Genitalis; Herpes Labialis; Infections
Helicase/primase inhibitor
PRITELIVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
07HQ1TJ4JE
Molecule Type:
Small molecule
Molecular Formula:
C18H18N4O3S2
Molecular Weight:
402.5
AlogP:
2.37
PSA:
106.25
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ALBITIAZOLIUM
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ALBITIAZOLIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
HKM715W3UT
Molecule Type:
Small molecule
Molecular Formula:
C24H42N2O2S2+2
Molecular Weight:
454.75
AlogP:
4.67
PSA:
48.22
HBD:
2.0
HBA:
#RotB:
17.0
Source:
NERISPIRDINE
2
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis; Spinal Cord Injuries
Sodium channel alpha subunit blocker
NERISPIRDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
G7M7YWO6CG
Molecule Type:
Small molecule
Molecular Formula:
C17H18FN3
Molecular Weight:
283.35
AlogP:
4.16
PSA:
21.06
HBD:
0.0
HBA:
#RotB:
4.0
Source:
N-ACETYLMANNOSAMINE
2
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases
Unknown
N-ACETYLMANNOSAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
A1O5EUP7KS
Molecule Type:
Small molecule
Molecular Formula:
C8H15NO6
Molecular Weight:
221.21
AlogP:
-3.08
PSA:
119.25
HBD:
5.0
HBA:
#RotB:
2.0
Source:
ONVANSERTIB
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms; Carcinoma, Pancreatic Ductal; Prostatic Neoplasms, Castration-Resistant
Serine/threonine-protein kinase PLK1 inhibitor
ONVANSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
67RM91WDHQ
Molecule Type:
Small molecule
Molecular Formula:
C24H27F3N8O3
Molecular Weight:
532.53
AlogP:
1.92
PSA:
134.66
HBD:
3.0
HBA:
#RotB:
7.0
Source:
NEOMYCIN
2
Small molecule
Investigational
Unknown
Unknown
Osteomyelitis; Neoplasms; Bacteremia; Crohn Disease; Pneumonia; Prediabetic State; Bacterial Infections; Eye Infections; Infections
Bacterial 70S ribosome inhibitor
NEOMYCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
I16QD7X297
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HALOFUGINONE
2
Small molecule
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne
Unknown
HALOFUGINONE
×
Maximum Phase:
2
First Approval:
None
UNII:
L31MM1385E
Molecule Type:
Small molecule
Molecular Formula:
C16H17BrClN3O3
Molecular Weight:
414.69
AlogP:
1.88
PSA:
84.22
HBD:
2.0
HBA:
#RotB:
4.0
Source:
EZLOPITANT
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Neurokinin 1 receptor antagonist
EZLOPITANT
×
Maximum Phase:
2
First Approval:
None
UNII:
3L098A8MPY
Molecule Type:
Small molecule
Molecular Formula:
C31H38N2O
Molecular Weight:
454.66
AlogP:
6.2
PSA:
24.5
HBD:
1.0
HBA:
#RotB:
8.0
Source:
SILIBININ
2
Small molecule
Investigational
Unknown
Unknown
Tobacco Use Disorder; Hepatitis C; Liver Failure; Prostatic Neoplasms, Castration-Resistant
Unknown
SILIBININ
×
Maximum Phase:
2
First Approval:
None
UNII:
4RKY41TBTF
Molecule Type:
Small molecule
Molecular Formula:
C25H22O10
Molecular Weight:
482.44
AlogP:
2.36
PSA:
155.14
HBD:
5.0
HBA:
#RotB:
4.0
Source:
ORG-25935
2
Small molecule
Investigational
Unknown
Unknown
Alcoholism; Panic Disorder; Schizophrenia
Glycine transporter 1 inhibitor
ORG-25935
×
Maximum Phase:
2
First Approval:
None
UNII:
55L20667O4
Molecule Type:
Small molecule
Molecular Formula:
C21H25NO3
Molecular Weight:
339.44
AlogP:
3.41
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
6.0
Source:
KRT-232
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
KRT-232
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DARINAPARSIN
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms; Bone Marrow Neoplasms; Carcinoma, Hepatocellular; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Multiple Myeloma
Unknown
DARINAPARSIN
×
Maximum Phase:
2
First Approval:
None
UNII:
9XX54M675G
Molecule Type:
Small molecule
Molecular Formula:
C12H22AsN3O6S
Molecular Weight:
411.31
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GIRIPLADIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Osteoarthritis
Cytosolic phospholipase A2 inhibitor
GIRIPLADIB
×
Maximum Phase:
2
First Approval:
None
UNII:
1W10Q5H7WD
Molecule Type:
Small molecule
Molecular Formula:
C41H36ClF3N2O4S
Molecular Weight:
745.26
AlogP:
9.49
PSA:
88.4
HBD:
2.0
HBA:
#RotB:
14.0
Source:
AMG-337
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Sarcoma, Clear Cell; Stomach Neoplasms
Hepatocyte growth factor receptor inhibitor
AMG-337
×
Maximum Phase:
2
First Approval:
None
UNII:
08WG8S0L8D
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STRONTIUM
2
Small molecule
Investigational
Unknown
Unknown
Osteoporosis
Unknown
STRONTIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
YZS2RPE8LE
Molecule Type:
Small molecule
Molecular Formula:
H2Sr
Molecular Weight:
89.64
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ISOXAFLUTOLE
2
Small molecule
Investigational
Unknown
Unknown
Herpes Labialis
Unknown
ISOXAFLUTOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
0T9R0O0EYT
Molecule Type:
Small molecule
Molecular Formula:
C15H12F3NO4S
Molecular Weight:
359.33
AlogP:
3.21
PSA:
77.24
HBD:
0.0
HBA:
#RotB:
4.0
Source:
DIMIRACETAM
2
Small molecule
Investigational
Unknown
Unknown
Acquired Immunodeficiency Syndrome
Unknown
DIMIRACETAM
×
Maximum Phase:
2
First Approval:
None
UNII:
4AW7F70MZO
Molecule Type:
Small molecule
Molecular Formula:
C6H8N2O2
Molecular Weight:
140.14
AlogP:
-0.94
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
0.0
Source:
REVEXEPRIDE
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
Serotonin 4 (5-HT4) receptor agonist
REVEXEPRIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
8C63R2Y02M
Molecule Type:
Small molecule
Molecular Formula:
C21H32ClN3O4
Molecular Weight:
425.96
AlogP:
2.08
PSA:
97.05
HBD:
3.0
HBA:
#RotB:
7.0
Source:
LEVOGLUCOSE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LEVOGLUCOSE
×
Maximum Phase:
2
First Approval:
None
UNII:
02833ISA66
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
ISOQUERCETIN
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Renal Cell; Anemia, Sickle Cell; Renal Insufficiency, Chronic; Severe Acute Respiratory Syndrome
Unknown
ISOQUERCETIN
×
Maximum Phase:
2
First Approval:
None
UNII:
6HN2PC637T
Molecule Type:
Small molecule
Molecular Formula:
C21H20O12
Molecular Weight:
464.38
AlogP:
-0.54
PSA:
210.51
HBD:
8.0
HBA:
#RotB:
4.0
Source:
GEDATOLISIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Triple Negative Breast Neoplasms; Breast Neoplasms; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
PI3-kinase class I inhibitor
GEDATOLISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
96265TNH2R
Molecule Type:
Small molecule
Molecular Formula:
C32H41N9O4
Molecular Weight:
615.74
AlogP:
3.02
PSA:
128.29
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MCPP
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MCPP
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY2623091
2
Small molecule
Investigational
Unknown
Unknown
Essential Hypertension; Renal Insufficiency, Chronic
Mineralocorticoid receptor antagonist
LY2623091
×
Maximum Phase:
2
First Approval:
None
UNII:
6FHZ595FNM
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SPERGUALIN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1
Unknown
SPERGUALIN
×
Maximum Phase:
2
First Approval:
None
UNII:
987K1SBI71
Molecule Type:
Small molecule
Molecular Formula:
C31H24ClF6N3O2
Molecular Weight:
619.99
AlogP:
7.57
PSA:
62.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TAS-108
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TAS-108
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENCYNONATE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Motion Sickness
Unknown
PHENCYNONATE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
54F576E38V
Molecule Type:
Small molecule
Molecular Formula:
C22H32ClNO3
Molecular Weight:
393.96
AlogP:
3.34
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CAMICINAL
2
Small molecule
Investigational
Unknown
Unknown
Gastroparesis
Motilin receptor agonist
CAMICINAL
×
Maximum Phase:
2
First Approval:
None
UNII:
3C8348951H
Molecule Type:
Small molecule
Molecular Formula:
C25H33FN4O
Molecular Weight:
424.56
AlogP:
3.27
PSA:
47.61
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LBH589
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LBH589
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MINNELIDE FREE SALT
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MINNELIDE FREE SALT
×
Maximum Phase:
2
First Approval:
None
UNII:
15OP6DI2OA
Molecule Type:
Small molecule
Molecular Formula:
C21H27O10P
Molecular Weight:
470.41
AlogP:
1.19
PSA:
139.88
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NRX-101
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NRX-101
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAY1067197
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure
Adenosine A1 receptor agonist
BAY1067197
×
Maximum Phase:
2
First Approval:
None
UNII:
IV690462VZ
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-03893787
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-03893787
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LUVADAXISTAT
2
Small molecule
Investigational
Unknown
Unknown
Friedreich Ataxia; Schizophrenia
Unknown
LUVADAXISTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
76IC00YRVR
Molecule Type:
Small molecule
Molecular Formula:
C13H11F3N2O2
Molecular Weight:
284.24
AlogP:
2.28
PSA:
65.98
HBD:
2.0
HBA:
#RotB:
3.0
Source:
1
2
…
108
109
110
111
112
113
114
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA